- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 747.15M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 823.39M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 550.15M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $11M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $4M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$157M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $23M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $3.14B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $0 |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $484M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $199M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.82B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $782M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.26B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $367M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.29B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $753M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.06B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $317M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $8.12B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.54B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.03 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.09 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.09 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $81M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $27M |
| Net Income | Q1 2026 · Mar 31, 2026 | $22M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$51M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$351M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$54M |
| Revenue | Q1 2026 · Mar 31, 2026 | $2.7B |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $1.36B |